Russell P Tracy Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

02/2008	Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study.
02/2007	Serum amyloid P and cardiovascular disease in older men and women: results from the Cardiovascular Health Study.
11/2006	Functional variants in the lymphotoxin-alpha gene predict cardiovascular disease in dialysis patients.
03/2006	IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort.
07/2005	Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort.
03/2004	Dietary fatty acids, hemostasis, and cardiovascular disease risk.
09/2003	Thrombin, inflammation, and cardiovascular disease: an epidemiologic perspective.
12/2002	In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease.
04/2002	No association of plasma prothrombin concentration or the G20210A mutation with incident cardiovascular disease: results from the Cardiovascular Health Study.

12	Inflammation 07/2008 - 01/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 02/2008 - 04/2002
7	Atherosclerosis (Atheroma) 09/2007 - 04/2002
5	Insulin Resistance 07/2005 - 04/2002
3	Syndrome 04/2006 - 08/2002
3	Coronary Disease (Coronary Heart Disease) 07/2005 - 08/2003
3	Myocardial Infarction 04/2004 - 05/2002
2	Obesity 08/2005 - 01/2003
2	Myocardial Ischemia (Ischemic Heart Diseases) 02/2003 - 02/2002
1	Rheumatoid Arthritis 09/2008
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2008
1	Kidney Diseases (Kidney Disease) 08/2006
1	Heart Failure 01/2006
1	Heart Diseases (Heart Disease) 10/2005
1	Sleep Apnea Syndromes (Sleep Apnea) 04/2005
1	Malnutrition 01/2004
1	Prediabetic State (Prediabetes) 10/2003
1	Stroke (Strokes) 04/2003
1	Venous Thrombosis (Deep-Vein Thrombosis) 02/2003
1	Renal Insufficiency 01/2003
1	Venous Thromboembolism 12/2002
1	Thromboembolism 12/2002

11	C-Reactive ProteinIBA 09/2008 - 04/2002
6	Insulin (Novolin)FDA Link 07/2004 - 01/2002
4	oxidized low density lipoproteinIBA 09/2007 - 08/2003
3	Biological Markers (Surrogate Marker)IBA 07/2008 - 01/2003
2	Fibrinogen (Factor I)IBA 02/2008 - 07/2005
2	Interleukin-6 (Interleukin 6)IBA 03/2006 - 12/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 06/2004 - 03/2004
2	Plasminogen Activators (Plasminogen Activator)IBA 05/2003 - 04/2002
2	Blood Coagulation Factors (Coagulation Factor)IBA 12/2002 - 02/2002
1	CalciumIBA 09/2008
1	glucuronyl glucosamine glycan sulfate (Vessel)IBA 07/2008
1	Amyloid (Amyloid Fibrils)IBA 02/2007
1	Lymphotoxin-alpha (Lymphotoxin)IBA 11/2006
1	HormonesIBA 01/2006
1	Messenger RNA (mRNA)IBA 01/2006
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2005
1	CholesterolIBA 01/2004
1	ThrombinIBA 09/2003
1	fibrin fragment D (D-dimer)IBA 02/2003
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2003
1	Prothrombin (Factor II)IBA 04/2002
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 04/2002
1	Glucose (Dextrose)FDA LinkGeneric 01/2002